Filed: 11/17/2025ACC: 0001315863-25-000814
📋 What this filing means
ARMISTICE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 328 equity positions with a total reported market value of $6.74B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
328
Positions
$6.74B
Total AUM (reported)
193.55M
Total Shares
Allocation by class
LISTED OPTION$3.56B52.7%
EQUITY$3.18B47.2%
WARRANT$5.74M0.1%
Portfolio Concentration
Top 3$3.56B52.8%
4–10$730.36M10.8%
11–25$801.73M11.9%
Rest$1.65B24.5%
Top 3 weight
52.8%
Top 10 weight
63.6%
Voting Authority Distribution
Total shares with voting rights: 193.55M
Sole
Full voting authority
193.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole328
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings328
Rows:
IWM NOV5 230.0 P
SOLEShares7M
TypeSH
Market value$1.69B
25.12%
Sole
7M
Shared
0.00
None
0.00
SPY NOV5 634.0 P
SOLEShares2.50M
TypeSH
Market value$1.67B
24.71%
Sole
2.50M
Shared
0.00
None
0.00
PTC THERAPEUTICS ORD
SOLEShares3.28M
TypeSH
Market value$201.13M
2.98%
Sole
3.28M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS ORD
SOLEShares6.72M
TypeSH
Market value$160.70M
2.38%
Sole
6.72M
Shared
0.00
None
0.00
SUPERNUS PHARMACEUTICALS ORD
SOLEShares2.84M
TypeSH
Market value$135.53M
2.01%
Sole
2.84M
Shared
0.00
None
0.00
INCYTE ORD
SOLEShares1.17M
TypeSH
Market value$99.01M
1.47%
Sole
1.17M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES ORD
SOLEShares697.02K
TypeSH
Market value$97.85M
1.45%
Sole
697.02K
Shared
0.00
None
0.00
IMMUNOVANT ORD
SOLEShares5.84M
TypeSH
Market value$94.08M
1.40%
Sole
5.84M
Shared
0.00
None
0.00
DENTSPLY SIRONA ORD
SOLEShares5.74M
TypeSH
Market value$72.79M
1.08%
Sole
5.74M
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS ORD
SOLEShares125.21K
TypeSH
Market value$70.40M
1.04%
Sole
125.21K
Shared
0.00
None
0.00
FRESHPET ORD
SOLEShares1.23M
TypeSH
Market value$68.05M
1.01%
Sole
1.23M
Shared
0.00
None
0.00
AMAZON COM ORD
SOLEShares309.40K
TypeSH
Market value$67.93M
1.01%
Sole
309.40K
Shared
0.00
None
0.00
CYTOKINETICS ORD
SOLEShares1.20M
TypeSH
Market value$65.78M
0.98%
Sole
1.20M
Shared
0.00
None
0.00
GE HEALTHCARE TECHNOLOGIES ORD
SOLEShares795.05K
TypeSH
Market value$59.71M
0.89%
Sole
795.05K
Shared
0.00
None
0.00
MDGL APR6 400.0C
SOLEShares130K
TypeSH
Market value$59.63M
0.88%
Sole
130K
Shared
0.00
None
0.00
EXACT SCIENCES ORD
SOLEShares1.03M
TypeSH
Market value$56.38M
0.84%
Sole
1.03M
Shared
0.00
None
0.00
ALPHABET CL A ORD
SOLEShares230.68K
TypeSH
Market value$56.08M
0.83%
Sole
230.68K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS ORD
SOLEShares119.98K
TypeSH
Market value$55.03M
0.82%
Sole
119.98K
Shared
0.00
None
0.00
CYTK JAN7 40.0 C
SOLEShares950K
TypeSH
Market value$52.21M
0.77%
Sole
950K
Shared
0.00
None
0.00
FIVE9 ORD
SOLEShares2M
TypeSH
Market value$48.40M
0.72%
Sole
2M
Shared
0.00
None
0.00
MICROSOFT ORD
SOLEShares87.25K
TypeSH
Market value$45.19M
0.67%
Sole
87.25K
Shared
0.00
None
0.00
ARGENX ADR REP ORD
SOLEShares58K
TypeSH
Market value$42.78M
0.63%
Sole
58K
Shared
0.00
None
0.00
TREACE MEDICAL CONCEPTS ORD
SOLEShares6.32M
TypeSH
Market value$42.38M
0.63%
Sole
6.32M
Shared
0.00
None
0.00
KURA ONCOLOGY ORD
SOLEShares4.67M
TypeSH
Market value$41.35M
0.61%
Sole
4.67M
Shared
0.00
None
0.00
NOVO NORDISK ADR REPSG 1 ORD
SOLEShares736K
TypeSH
Market value$40.84M
0.61%
Sole
736K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IWM NOV5 230.0 PSOLE | LISTED OPTION | 7M | SH | $1.69B 25.12% | 7M | 0.00 | 0.00 |
SPY NOV5 634.0 PSOLE | LISTED OPTION | 2.50M | SH | $1.67B 24.71% | 2.50M | 0.00 | 0.00 |
PTC THERAPEUTICS ORDSOLE | EQUITY | 3.28M | SH | $201.13M 2.98% | 3.28M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS ORDSOLE | EQUITY | 6.72M | SH | $160.70M 2.38% | 6.72M | 0.00 | 0.00 |
SUPERNUS PHARMACEUTICALS ORDSOLE | EQUITY | 2.84M | SH | $135.53M 2.01% | 2.84M | 0.00 | 0.00 |
INCYTE ORDSOLE | EQUITY | 1.17M | SH | $99.01M 1.47% | 1.17M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES ORDSOLE | EQUITY | 697.02K | SH | $97.85M 1.45% | 697.02K | 0.00 | 0.00 |
IMMUNOVANT ORDSOLE | EQUITY | 5.84M | SH | $94.08M 1.40% | 5.84M | 0.00 | 0.00 |
DENTSPLY SIRONA ORDSOLE | EQUITY | 5.74M | SH | $72.79M 1.08% | 5.74M | 0.00 | 0.00 |
REGENERON PHARMACEUTICALS ORDSOLE | EQUITY | 125.21K | SH | $70.40M 1.04% | 125.21K | 0.00 | 0.00 |
FRESHPET ORDSOLE | EQUITY | 1.23M | SH | $68.05M 1.01% | 1.23M | 0.00 | 0.00 |
AMAZON COM ORDSOLE | EQUITY | 309.40K | SH | $67.93M 1.01% | 309.40K | 0.00 | 0.00 |
CYTOKINETICS ORDSOLE | EQUITY | 1.20M | SH | $65.78M 0.98% | 1.20M | 0.00 | 0.00 |
GE HEALTHCARE TECHNOLOGIES ORDSOLE | EQUITY | 795.05K | SH | $59.71M 0.89% | 795.05K | 0.00 | 0.00 |
MDGL APR6 400.0CSOLE | LISTED OPTION | 130K | SH | $59.63M 0.88% | 130K | 0.00 | 0.00 |
EXACT SCIENCES ORDSOLE | EQUITY | 1.03M | SH | $56.38M 0.84% | 1.03M | 0.00 | 0.00 |
ALPHABET CL A ORDSOLE | EQUITY | 230.68K | SH | $56.08M 0.83% | 230.68K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS ORDSOLE | EQUITY | 119.98K | SH | $55.03M 0.82% | 119.98K | 0.00 | 0.00 |
CYTK JAN7 40.0 CSOLE | LISTED OPTION | 950K | SH | $52.21M 0.77% | 950K | 0.00 | 0.00 |
FIVE9 ORDSOLE | EQUITY | 2M | SH | $48.40M 0.72% | 2M | 0.00 | 0.00 |
MICROSOFT ORDSOLE | EQUITY | 87.25K | SH | $45.19M 0.67% | 87.25K | 0.00 | 0.00 |
ARGENX ADR REP ORDSOLE | EQUITY | 58K | SH | $42.78M 0.63% | 58K | 0.00 | 0.00 |
TREACE MEDICAL CONCEPTS ORDSOLE | EQUITY | 6.32M | SH | $42.38M 0.63% | 6.32M | 0.00 | 0.00 |
KURA ONCOLOGY ORDSOLE | EQUITY | 4.67M | SH | $41.35M 0.61% | 4.67M | 0.00 | 0.00 |
NOVO NORDISK ADR REPSG 1 ORDSOLE | EQUITY | 736K | SH | $40.84M 0.61% | 736K | 0.00 | 0.00 |
Page 1 of 14
…